Adhesion to digestive mucosa is considered a crucial first step in the pathogenicity of invasive Candida infections. Candida glabrata disseminated infections predominantly start from the gut. A mouse model of disseminated infection starting from the gut was set up. Hematogenous dissemination was obtained after a low-protein diet followed by a regimen of cyclophosphamide-methotrexate and an oral inoculation of the yeasts via the drinking water. The liver was the first organ infected (day 7 post-infection), and lethality was 100% at day 21 post-infection. This new mouse model was used to compare the mortality rate and fungal burden in deep organs induced by 5 strains exhibiting different levels of adhesion to enterocyte Caco-2 cells, as determined in a test on 36 C. glabrata strains. In this model, no statistical difference of lethality was demonstrated between the strains, and fungal burden varied in kidneys and lungs but without correlation with the level of adhesion to enterocytes. Further studies using the model developed here allow analysis of the crossing of the digestive mucosa by yeasts, and help relate this to yet-poorly understood adhesion phenotypes.
References
[1]
Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546–1554.
[2]
Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, et al. (2011) Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 6: e24198.
[3]
Pfaller MA, Diekema DJ (2010) Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 36: 1–53.
[4]
Klevay MJ, Ernst EJ, Hollanbaugh JL, Miller JG, Pfaller MA, et al. (2008) Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagn Microbiol Infect Dis 60: 273–277.
[5]
Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, et al. (1999) National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29: 253–258.
[6]
Hedderwick SA, Lyons MJ, Liu M, Vazquez JA, Kauffman CA (2000) Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis 19: 663–670.
[7]
Fidel PL, Vazquez JA, Sobel JD (1999) Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12: 80–96.
[8]
Yan L, Yang C, Tang J (2013) Disruption of the intestinal mucosal barrier in Candida albicans infections. Microbiol Res. ePub DOI 10.1016/j.micres.2013.02.008.
[9]
Moran AP, Gupta A, Joshi L (2011) Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut 60: 1412–1425.
[10]
Maestre-Reyna M, Diderrich R, Veelders MS, Eulenburg G, Kalugin V, et al. (2012) Structural basis for promiscuity and specificity during Candida glabrata invasion of host epithelia. Proc Natl Acad Sci U S A 109: 16864–16869.
[11]
Castano I, Pan SJ, Zupancic M, Hennequin C, Dujon B, et al. (2005) Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata. Mol Microbiol 55: 1246–1258.
[12]
Cormack BP, Ghori N, Falkow S (1999) An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 285: 578–582.
[13]
Enache-Angoulvant A, Bourget M, Brisse S, Stockman-Pannier C, Diancourt L, et al. (2010) Multilocus microsatellite markers for molecular typing of Candida glabrata: application to analysis of genetic relationships between bloodstream and digestive system isolates. J Clin Microbiol 48: 4028–4034.
[14]
Brisse S, Pannier C, Angoulvant A, de Meeus T, Diancourt L, et al. (2009) Uneven distribution of mating types among genotypes of Candida glabrata isolates from clinical samples. Eukaryot Cell 8: 287–295.
[15]
Pinto M, Robine-Leone S, Appay M, Kedinger M, Triadou N, et al. (1983) Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47: 323–330.
[16]
Kurioka T, Yunou Y, Kita E (1998) Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun 66: 1726–1734.
[17]
Pfaller MA (2012) Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125: S3–13.
[18]
Chapeland-Leclerc F, Hennequin C, Papon N, Noel T, Girard A, et al. (2010) Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient. Antimicrob Agents Chemother 54: 1360–1362.
[19]
Grenouillet F, Millon L, Bart J-M, Roussel S, Biot I, et al. (2007) Multiple-locus variable-number tandem-repeat analysis for rapid typing of Candida glabrata. J Clin Microbiol 45: 3781–3784.
[20]
Olson JA, Adler-Moore JP, Smith PJ, Proffitt RT (2005) Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Antimicrob Agents Chemother 49: 4895–4902.
[21]
Ferrari S, Sanguinetti M, De Bernardis F, Torelli R, Posteraro B, et al. (2011) Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother 55: 1852–1860.
[22]
Brieland J, Essig D, Jackson C, Frank D, Loebenberg D, et al. (2001) Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect Immun 69: 5046–5055.
[23]
Koh AY, K？hler JR, Coggshall KT, Van Rooijen N, Pier GB (2008) Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS pathogens 4: e35.
[24]
Jawhara S, Mogensen E, Maggiotto F, Fradin C, Sarazin A, et al. (2012) Murine model of dextran sulfate sodium-induced colitis reveals Candida glabrata virulence and contribution of beta-mannosyltransferases. J Biol Chem 287: 11313–11324.
[25]
Takahashi K, Kita E, Konishi M, Yoshimoto E, Mikasa K, et al. (2003) Translocation model of Candida albicans in DBA-2/J mice with protein calorie malnutrition mimics hematogenous candidiasis in humans. Microb Pathog 35: 179–187.
[26]
De Las Penas A, Pan SJ, Castano I, Alder J, Cregg R, et al. (2003) Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1- and SIR-dependent transcriptional silencing. Genes Dev 17: 2245–2258.
[27]
Dalle F, W？chtler B, L’ollivier C, Holland G, Bannert N, et al. (2010) Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol 12: 248–271.
[28]
Domergue R, Castano I, De Las Penas A, Zupancic M, Lockatell V, et al. (2005) Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308: 866–870.
[29]
Zupancic ML, Frieman M, Smith D, Alvarez RA, Cummings RD, et al. (2008) Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol Microbiol 68: 547–559.
[30]
Brun S, Dalle F, Saulnier P, Renier G, Bonnin A, et al. (2005) Biological consequences of petite mutations in Candida glabrata. J Antimicrob Chemother 56: 307–314.
[31]
Kuhn DM, Vyas VK (2012) The Candida glabrata adhesin Epa1p causes adhesion, phagocytosis, and cytokine secretion by innate immune cells. FEMS Yeast Res 12: 398–414.
[32]
Nielsen K, Heitman J (2007) Sex and virulence of human pathogenic fungi. Adv Genet 57: 143–173.
[33]
L’Ollivier C, Labruère C, Jebrane A, Bougnoux M-E, D’Enfert C, et al. (2012) Using a Multi-Locus Microsatellite Typing method improve phylogenetic distribution of Candida albicans isolates but failed to demonstrate association of some genotype with the commensal or clinical origin of the isolates. Infect Genet Evol 12: 1949–1957.
[34]
Halliwell SC, Smith MC, Muston P, Holland SL, Avery SV (2012) Heterogeneous expression of the virulence-related adhesin Epa1 between individual cells and strains of the pathogen Candida glabrata. Eukaryot Cell 11: 141–150.
[35]
Romani L (2011) Immunity to fungal infections. Nature Rev Immunol 11: 275.
[36]
Berg RD (1999) Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol 473: 11–30.
[37]
Shoham S, Levitz SM (2005) The immune response to fungal infections. Br J Haematol 129: 569–582.
